The Nanomedicine and Nanotoxicology Group at IFSC-USP has engineered hydroxyapatite nanoparticles to exhibit enhanced intrinsic luminescence, a significant advancement for medical applications.
This transformation of hydroxyapatite, a bioceramic material, into luminescent nanoparticles could improve imaging techniques and therapeutic approaches in oncology.
The implications of this research extend to the architecture of biomedical imaging systems, potentially increasing throughput and efficiency in cancer treatment modalities.